AbbVie Inks a Deal With Neomorph for Molecular Glue Degraders

Published on 24 Jan 2025 on Zacks · via Yahoo Finance

AbbVie Inc. Price AbbVie Inc. price | AbbVie Inc. Quote ABBV’s Zacks Rank AbbVie currently carries a...

Read the rest of the article

Start tracking your investments with Statfolio

We recently published a list of Jim Cramer’s Thoughts on These 7 Stocks. In this article, we are...

Insider Monkey · via Yahoo Finance 1 Feb 2025

Biogen (BIIB) has an impressive earnings surprise history and currently possesses the right...

Zacks · via Yahoo Finance 29 Jan 2025

Sage Therapeutics turns down Biogen's offer to buy the remaining stake in the company and is...

Zacks · via Yahoo Finance 28 Jan 2025

The FDA's approval is based on simulation data from multiple studies showing that maintenance dos...

Zacks · via Yahoo Finance 27 Jan 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) stock climbed 2.5% today, reflecting investor sentiment aft...

Investing.com 27 Jan 2025

Free Report) announced that the FDA has approved a monthly maintenance dosing version for its...

Zacks 27 Jan 2025

AbbVie Inc. Price AbbVie Inc. price | AbbVie Inc. Quote ABBV’s Zacks Rank AbbVie currently carrie...

Zacks · via Yahoo Finance 24 Jan 2025

BIIB's regulatory filings are supported by late-stage data, which show that treatment with a high...

Zacks · via Yahoo Finance 24 Jan 2025

Shares of Ionis Pharmaceuticals (NASDAQ:IONS) climbed 7% today after the company announced that...

Investing.com 23 Jan 2025

U.S. stocks mixed at close of trade; Dow Jones Industrial Average up 0.52%

Investing.com 14 Jan 2025